Impact of the 2019 Food and Drug Administration Guidance for Uncomplicated Urinary Tract Infection on Treatment Response Rates: A Reanalysis of a Clinical Trial of Nitrofurantoin vs Fosfomycin

BACKGROUND: Current US Food and Administration (FDA) guidance recommends that the primary efficacy endpoint for uncomplicated urinary tract infection (uUTI) clinical trials be a composite of clinical and microbiological responses. We applied these criteria to a previous clinical trial to determine t...

Descripción completa

Detalles Bibliográficos
Autores principales: Grant, Rebecca, Büchler, Andrea, Flight, William, Huang, Chun, Ferrinho, Diogo, Janmohamed, Salim, Mulgirigama, Aruni, Godycki-Cwirko, Maciek, Leibovici, Leonard, Huttner, Angela, Harbarth, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661658/
https://www.ncbi.nlm.nih.gov/pubmed/38023546
http://dx.doi.org/10.1093/ofid/ofad557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661658/
https://www.ncbi.nlm.nih.gov/pubmed/38023546
http://dx.doi.org/10.1093/ofid/ofad557

Ejemplares similares